Perrigo reported $434.8M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.24B 117M Dec/2025
Bayer EUR 6.59B 496M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Dr.Reddys Laboratories INR 30.38B 10.42B Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Merck USD 3.86B 541M Mar/2026
Nestle CHF 20.2B 727M Dec/2025
Pacira USD 14.01M 1.14M Mar/2026
Perrigo USD 434.8M 39.7M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Reckitt Benckiser GBP 2.27B 2.85B Dec/2024
Sanofi EUR 22.71B 219M Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026
Zoetis USD 507M 20M Mar/2026